RU2016148174A3 - - Google Patents

Download PDF

Info

Publication number
RU2016148174A3
RU2016148174A3 RU2016148174A RU2016148174A RU2016148174A3 RU 2016148174 A3 RU2016148174 A3 RU 2016148174A3 RU 2016148174 A RU2016148174 A RU 2016148174A RU 2016148174 A RU2016148174 A RU 2016148174A RU 2016148174 A3 RU2016148174 A3 RU 2016148174A3
Authority
RU
Russia
Application number
RU2016148174A
Other versions
RU2016148174A (ru
RU2706688C2 (ru
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of RU2016148174A publication Critical patent/RU2016148174A/ru
Publication of RU2016148174A3 publication Critical patent/RU2016148174A3/ru
Application granted granted Critical
Publication of RU2706688C2 publication Critical patent/RU2706688C2/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4995Pyrazines or piperazines forming part of bridged ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
RU2016148174A 2014-05-09 2014-05-09 Фармацевтически приемлемые соли энантиомеров пирлиндола для применения в медицине RU2706688C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/PT2014/000026 WO2015171002A1 (en) 2014-05-09 2014-05-09 Pharmaceutically acceptable salts of pirlindole enantiomers for use in medicine

Publications (3)

Publication Number Publication Date
RU2016148174A RU2016148174A (ru) 2018-06-14
RU2016148174A3 true RU2016148174A3 (ru) 2018-06-14
RU2706688C2 RU2706688C2 (ru) 2019-11-20

Family

ID=50819928

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2016148174A RU2706688C2 (ru) 2014-05-09 2014-05-09 Фармацевтически приемлемые соли энантиомеров пирлиндола для применения в медицине

Country Status (18)

Country Link
US (1) US10226460B2 (ru)
EP (2) EP3139926A1 (ru)
JP (1) JP6400121B2 (ru)
KR (1) KR102276281B1 (ru)
CN (1) CN106413713B (ru)
AU (1) AU2014393487B2 (ru)
CA (1) CA2948595C (ru)
EC (1) ECSP16086196A (ru)
IL (1) IL248852B (ru)
MA (1) MA39450B2 (ru)
MX (1) MX2016014704A (ru)
NZ (1) NZ726127A (ru)
PH (1) PH12016502235A1 (ru)
RU (1) RU2706688C2 (ru)
SA (1) SA516380258B1 (ru)
TN (1) TN2016000495A1 (ru)
UA (1) UA118587C2 (ru)
WO (1) WO2015171002A1 (ru)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20170145015A1 (en) * 2014-05-09 2017-05-25 Tecnimede Sociedade Tecnico-Medicinal S.A. (r)-pirlindole and its pharmaceutically acceptable salts for use in medicine
NO3057589T3 (ru) * 2014-05-09 2017-12-30
EP3392251A1 (en) * 2017-04-21 2018-10-24 Tecnimede-Sociedade Tecnico-Medicinal, S.A. Process for the preparation of pirlindole enantiomers and its salts
EP3392250A1 (en) * 2017-04-21 2018-10-24 Tecnimede-Sociedade Tecnico-Medicinal, S.A. Process for the preparation of piperazine ring for the synthesis of pyrazinocarbazole derivatives

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK170473B1 (da) 1985-06-20 1995-09-11 Daiichi Seiyaku Co S(-)-pyridobenzoxazinforbindelser
MXPA05003550A (es) * 2002-10-03 2006-01-24 Cypress Bioscience Inc Incremento de dosificacion y dosis diaria dividida de anti-depresivos para tratar padecimientos neurologicos.
EP1688161A1 (en) * 2004-11-02 2006-08-09 Switch Biotech Aktiengesellschaft Use of pirlindole for the treatment of diseases which are characterized by proliferation of t-lymphocytes and/or hyperproliferation of keratinocytes in particular atopic dermatitis and psoriasis
CA2747235C (en) * 2008-12-11 2021-02-09 Biovista, Inc. Methods for treating multiple sclerosis using tetracyclic pyrazinoindoles
WO2014062621A1 (en) * 2012-10-15 2014-04-24 Stc.Unm Treatment of autophagy-based disorders and related pharmaceutical compositions, diagnostic and screening assays and kits
US20170145015A1 (en) * 2014-05-09 2017-05-25 Tecnimede Sociedade Tecnico-Medicinal S.A. (r)-pirlindole and its pharmaceutically acceptable salts for use in medicine
WO2015171003A1 (en) * 2014-05-09 2015-11-12 Tecnimede Sociedade Tecnico-Medicinal S.A. Process for obtaining optically active pirlindole enantiomers and salts thereof
NO3057589T3 (ru) * 2014-05-09 2017-12-30

Also Published As

Publication number Publication date
KR102276281B1 (ko) 2021-07-13
RU2016148174A (ru) 2018-06-14
MA39450B2 (fr) 2021-10-29
KR20170002433A (ko) 2017-01-06
CA2948595A1 (en) 2015-11-12
US10226460B2 (en) 2019-03-12
TN2016000495A1 (en) 2018-04-04
IL248852B (en) 2020-05-31
CA2948595C (en) 2021-07-13
NZ726127A (en) 2019-03-29
WO2015171002A1 (en) 2015-11-12
ECSP16086196A (es) 2017-02-24
PH12016502235A1 (en) 2017-01-09
EP3139926A1 (en) 2017-03-15
AU2014393487B2 (en) 2020-01-02
RU2706688C2 (ru) 2019-11-20
IL248852A0 (en) 2017-01-31
AU2014393487A1 (en) 2016-11-24
EP3831385A1 (en) 2021-06-09
CN106413713B (zh) 2020-07-14
CN106413713A (zh) 2017-02-15
SA516380258B1 (ar) 2019-11-04
MX2016014704A (es) 2017-05-23
UA118587C2 (uk) 2019-02-11
JP6400121B2 (ja) 2018-10-03
US20170143710A1 (en) 2017-05-25
JP2017514882A (ja) 2017-06-08
MA39450A1 (fr) 2017-08-31

Similar Documents

Publication Publication Date Title
BR112016027939A2 (ru)
BR112016030846A2 (ru)
RU2017118173A3 (ru)
BR112016026713A2 (ru)
BR112016026285A2 (ru)
BR112016013819A2 (ru)
BR112016030939A2 (ru)
BR112016021214A2 (ru)
BR112016027833A2 (ru)
RU2015102214A3 (ru)
BR112016016657A2 (ru)
BR112016012729A2 (ru)
BR112016026629A2 (ru)
BR122020016505A2 (ru)
BR112016019161A2 (ru)
BR112016015625A2 (ru)
RU2016148174A3 (ru)
BR112016023267A2 (ru)
BR112016030775A2 (ru)
BR112016026558A2 (ru)
BR112016026907A2 (ru)
BR112016015192A2 (ru)
BR112016014859A2 (ru)
JP1544531S (ru)
JP1529692S (ru)